Creating a Theranostics ProgramHow do you find the personalized support you need to create, build, equip, and finance your theranostics program?
Novel radioligand diagnostics and therapies for conditions like Neuroendocrine and Prostate Cancer are on the rise, making patient access to this new oncology service more critical than ever. With a host of clinical trials in this emerging space, the demand for theranostics is set to grow even further with new diagnostic and treatment indications.
To effectively deliver theranostics solutions to your patients, you’ll need specific types of support. Here’s what to consider.
210 PET Imaging shares how they built a theranostics program
In this case study, Steve Wozniak, Associate Director of Molecular Imaging & Theranostics, and Andrew Moran, MD, Chief Radiologist of Nuclear Medicine at 210 PET Imaging, share their learnings and recommendations for other providers. Read what they have to say about building a theranostics program.
